Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (231-240 of 264) with videos related to

Pageof 27
Sort By:
Hepatology Communications|February 8, 2022
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed LiverCristina Quintavalle, Nathalie Meyer-Schaller, Stephanie Roessler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
mRNA expression signature of Gleason grade predicts lethal prostate cancerKathryn L Penney, Jennifer A Sinnott, Katja Fall, et al.
Nature Communications|November 25, 2018
Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of YapYoungmin A Lee, Luke A Noon, Kemal M Akat, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
Journal of the National Cancer Institute|May 29, 2008
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancerSunita R Setlur, Kirsten D Mertz, Yujin Hoshida, et al.
The New England Journal of Medicine|October 17, 2008
Gene expression in fixed tissues and outcome in hepatocellular carcinomaYujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, et al.
The Journal of Clinical Investigation|September 11, 2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease modelsEmilie Crouchet, Eugénie Schaeffer, Marine A Oudot, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
JCI Insight|July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivationEmilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Cancer Research|November 28, 2019
Correction: Recent Developments and Therapeutic Strategies against Hepatocellular CarcinomaMark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Pageof 27

Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
Hepatology Communications|February 8, 2022
miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed LiverCristina Quintavalle, Nathalie Meyer-Schaller, Stephanie Roessler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
mRNA expression signature of Gleason grade predicts lethal prostate cancerKathryn L Penney, Jennifer A Sinnott, Katja Fall, et al.
Nature Communications|November 25, 2018
Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of YapYoungmin A Lee, Luke A Noon, Kemal M Akat, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
Journal of the National Cancer Institute|May 29, 2008
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancerSunita R Setlur, Kirsten D Mertz, Yujin Hoshida, et al.
The New England Journal of Medicine|October 17, 2008
Gene expression in fixed tissues and outcome in hepatocellular carcinomaYujin Hoshida, Augusto Villanueva, Masahiro Kobayashi, et al.
The Journal of Clinical Investigation|September 11, 2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease modelsEmilie Crouchet, Eugénie Schaeffer, Marine A Oudot, et al.
Nature|February 4, 2011
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progressionZhihu Ding, Chang-Jiun Wu, Gerald C Chu, et al.
JCI Insight|July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivationEmilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.
Cancer Research|November 28, 2019
Correction: Recent Developments and Therapeutic Strategies against Hepatocellular CarcinomaMark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.
Pageof 27